Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
The British Journal of Diabetes & Vascular Disease
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Ferrannini, E.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Pre-diabetes: to treat or not to treat?

Ele Ferrannini

Department of Internal Medicine, Via Savi, 8, 56100 Pisa, Italy, ferranni{at}ifc.cnr.it

The prevalence of diabetes is increasing worldwide, bringing personal and economic burdens. Impaired glucose tolerance (IGT) generally precedes type 2 diabetes and strategies which target IGT and delay or prevent the onset of type 2 diabetes are being explored. IGT and type 2 diabetes are characterised by insulin resistance. Lifestyle and pharmacological approaches which ameliorate insulin resistance are being investigated as methods of diabetes prevention.

Key Words: IGT • pre-diabetes • diabetes prevention.

References

  • International Diabetes Federation. Diabetes Atlas 2000.
  • Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 1997;14(suppl 5):S1-S85.[Medline] [Order article via Infotrieve]
  • Boyle JP, Honeycutt AA, Narayan KM et al. Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. Diabetes Care 2001;24:1936-40.[Abstract/Free Full Text]
  • Mokdad AS, Ford EH, Bowman BA et al. Diabetes trends in the US: 1990-1998. Diabetes Care 2000;23:1278-83.[Abstract/Free Full Text]
  • Paeratakul S., Lovejoy JC, Ryan DH, Bray GA The relation of gender, race and socioeconomic status to obesity and obesity comorbidities in a sample of US adults. Int J Obes Relat Metab Disord 2002;26:1205-10.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Swinburn BA, Metcalf PA, Ley SJ Long-term (5-year) effects of a reduced-fat diet intervention in individuals with glucose intolerance. Diabetes Care 2001;24:619-24.[Abstract/Free Full Text]
  • Hu FB, Leitzmann MF, Stampfer MJ et al. Physical activity and television watching in relation to risk for type 2 diabetes mellitus in men. Arch Intern Med 2001;161:1542-8.[Abstract/Free Full Text]
  • Burrows NR, Geiss LS, Engelgau MM, Acton KJ Prevalence of diabetes among Native Americans and Alaska Natives, 1990-1997: an increasing burden. Diabetes Care 2000;23:1278-83.[Abstract/Free Full Text]
  • Lorenzo C., Serrano-Rios M., Martinez-Larrad MT et al. Was the historic contribution of Spain to the Mexican gene pool partially responsible for the higher prevalence of type 2 diabetes in Mexican-origin populations? The Spanish Insulin Resistance Study Group, the San Antonio Heart Study, and the Mexico City Diabetes Study. Diabetes Care 2001;24: 2059-64.[Abstract/Free Full Text]
  • Burden AC Blood pressure control and cardiovascular risk in patients of Indo-Asian and African-Caribbean descent. Int J Clin Pract 1998;52: 388-94.[Web of Science][Medline] [Order article via Infotrieve]
  • Abate N., Chandalia M. Ethnicity and type 2 diabetes: focus on Asian Indians. J Diabetes Complications 2001;15:320-7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Aschner P. Diabetes trends in Latin America. Diabetes Metab Res Rev 2002;18(suppl 3):S27-S31.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Skyler JS, Oddo C. Diabetes trends in the USA. Diabetes Metab Res Rev 2002;18(suppl 3):S21-S26.
  • Bagust A., Hopkinson PK, Maier W., Currie CJ An economic model of the long-term health care burden of type II diabetes. Diabetologia 2001;44:2140-55.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Bagust A., Hopkinson PK, Maslove L., Currie CJ The projected health care burden of Type 2 diabetes in the UK from 2000 to 2060. Diabet Med 2002;19(suppl 4):1-5.[Web of Science][Medline] [Order article via Infotrieve]
  • Gray A., Raikou M., McGuire A. et al. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). BMJ 2000; 320:1373-8.[Abstract/Free Full Text]
  • Clarke P., Gray A., Adler A. et al. Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No. 51). Diabetologia 2001;44:298-304.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • UK Prospective Diabetes Study Group. Intensive blood glucose control with sulphonylurea or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • DeFronzo RA, Bonnadonna RC, Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 1992;15:318-68.[Abstract]
  • DeFronzo RA Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerosis. Neth J Med 1997;50:191-7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Köhler C., Henkel E., Temelkova-Kurktschiev T. et al. Incidence of impaired fasting glucose, impaired glucose tolerance and type 2 diabetes in a German risk population: the RIAD study. Diabetologia 2001; 44(suppl 1):A108.[CrossRef]
  • American Diabetes Association. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-97.[Web of Science][Medline] [Order article via Infotrieve]
  • Lim SC, Tai ES, Tan BY, Chew SK, Tan CE Cardiovascular risk profile in individuals with borderline glycemia: the effect of the 1997 American Diabetes Association diagnostic criteria and the 1998 World Health Organization Provisional Report. Diabetes Care 2000;23:278-82.[Abstract]
  • Temelkova-Kurktschiev T., Siegert G., Bergmann S. et al. Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes. Metabolism 2002;51:743-9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Hanefeld M., Köhler C., Henkel E. Post-challenge hyperglycaemia relates more strongly than fasting hyperglycaemia with carotid intimamedia thickness: the RIAD Study. Risk factors in impaired glucose tolerance for atherosclerosis and diabetes. Diabet Med 2000;17:835-40.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Saydah SH, Miret M., Sung J., Varas C., Gause D., Brancati FL Postchallenge hyperglycemia and mortality in a national sample of U.S. adults. Diabetes Care 2001;24:1397-402.[Abstract/Free Full Text]
  • Tuomilehto J., Lindstrom J., Eriksson JG et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-50.[Abstract/Free Full Text]
  • Pan XR, Li GW, Hu YH et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care 1997;20:537-44.[Abstract]
  • Wenying Y., Lixiang L., Jinwu Q., Guangwei L., Zhiqing Y., Xiaoren P. The preventive effect of acarbose and metformin on the IGT population from becoming diabetes mellitus: a 3-year multicentral prospective study. Chin J Endocrinol Metab 2001;17:131-4.
  • Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.[Abstract/Free Full Text]
  • Chiasson J-L., Josse RG, Gomis R., Hanefeld M., Karasik A., Laakso M. Acarbose can prevent the progression of impaired glucose tolerance to type 2 diabetes mellitus: results of a randomised clinical trial: the STOP-NIDDM trial. Lancet 2002;359:2072-7[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

The British Journal of Diabetes & Vascular Disease, Vol. 3, No. 1 suppl, S2-S5 (2003)
DOI: 10.1177/14746514030030010201
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Ferrannini, E.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?